Outsourcing in Discovery Chemistry Strategy Selection SuccessHansjoerg Lehmann, Novartis Pharma AG, speaking at Discovery Chemistry Congress 2012.
Outsourcing Chemical Synthesis in the Drug Discovery ProcessGunter Festel, Autodisplay Biotech, speaking at Discovery Chemistry Congress 2012
The Potassium Channels Kv1.3 and KCa3.1 as Targets for Inflammatory Brain PathologiesProfessor Heike Wulff, University of California, speaking at Ion Channel Targets 2011.
Alpha2* Nicotinic Acetylcholine Receptors as a Therapeutic Target for Memory EnhancementDr Katumi Sumikawa, University of California, speaking at Ion Channel Targets 2011.
Smooth Muscle Kv7 (KCNQ) Potassium Channels: Important New Therapeutic TargetsProfessor Kenneth Byron, Loyola University Chigaco, speaking at Ion Channel Targets 2011.
Protons, Heat and Mechanical Force Converge to Gate Two-Pore Potassium Channels at the Selectivity FilterDr Slav Bagriantsev, University of California, speaking at Ion Channel Targets 2011.
Patent Pheromones: Attracting Money, Repelling Infringement, Prompting a Mating ResponseThomas Saunders, Of Counsel, Rissman Hendricks & Oliverio, speaking at Medchem Europe 2011.
Latent Hit Identification in Primary Screening Data with Compound Set EnrichmentThibault Varin, PostDoctoral Fellow, Novartis, Speaking at Medchem Europe 2011.
Current Perspectives in Fragment Based Ligand DiscoveryRoderick Hubbard, Professor, University of York, speaking at Medchem Europe 2011
About Us | Advertise On This Site | Cookies | Contact Us | Home | Support | Terms & Conditions